Augmentin Should NOT Be Used to Treat C. difficile Infection
Augmentin (amoxicillin-clavulanate) is not an effective treatment for C. difficile infection and should never be used for this purpose. In fact, Augmentin is a well-recognized risk factor for causing C. difficile infection and can worsen existing disease 1, 2, 3.
Why Augmentin Fails for CDI
Augmentin lacks activity against C. difficile in the clinical setting. While laboratory studies show that C. difficile isolates may be sensitive to amoxicillin-clavulanate in vitro 4, this does not translate to clinical efficacy for treating CDI 4. The drug is actually classified as a high-risk antibiotic that promotes C. difficile overgrowth and toxin production 2, 3.
The Correct Treatment Approach
For Initial CDI Episodes
Oral vancomycin 125 mg four times daily for 10 days is the first-line treatment for both mild-moderate and severe C. difficile infection 1, 2, 3. This represents a major shift from older guidelines that favored metronidazole, as vancomycin demonstrates superior clinical outcomes with high-quality evidence 1, 2.
Fidaxomicin 200 mg twice daily for 10 days is an equally effective alternative, particularly valuable for elderly patients or those with multiple comorbidities who face higher recurrence risk 1, 2, 3.
Metronidazole should only be used in resource-limited settings where vancomycin or fidaxomicin are unavailable, and only for nonsevere initial episodes 1. Avoid repeated courses due to cumulative neurotoxicity risk 1, 2.
For Severe or Fulminant CDI
Increase vancomycin to 500 mg orally four times daily plus add intravenous metronidazole 500 mg three times daily for patients with hypotension, shock, ileus, or toxic megacolon 5, 6, 2.
Add rectal vancomycin 500 mg in 100 mL normal saline every 6 hours as retention enema if ileus prevents oral medication from reaching the colon 5, 6.
Obtain immediate surgical consultation for patients with WBC ≥25,000, lactate ≥5 mmol/L, ileus, toxic megacolon, or peritoneal signs 2, 3.
For Recurrent CDI
Fidaxomicin 200 mg twice daily for 10 days is preferred for first recurrence, demonstrating lower recurrence rates (15.4%) compared to vancomycin (25.3%) 6, 2.
Fecal microbiota transplantation (FMT) is highly effective after ≥2 recurrences, with clinical resolution rates of 87-92% compared to 40-50% with antibiotics alone 7, 6, 2, 3.
Critical Action: Stop the Offending Antibiotic
The single most important intervention is to discontinue Augmentin or any other inciting antibiotic immediately if the patient is currently taking it 1, 6, 2, 3. Continued use of the offending antibiotic decreases clinical response and increases recurrence rates 1.
If continued antibiotics are necessary for another infection, switch to lower-risk agents: parenteral aminoglycosides, sulfonamides, macrolides, or tetracyclines/tigecycline 2, 3.
Avoid high-risk antibiotics including clindamycin, third-generation cephalosporins, penicillins (including Augmentin), and fluoroquinolones, as these are strongly associated with CDI development and recurrence 2, 3.
Common Pitfalls to Avoid
Never use intravenous vancomycin for CDI—it is not excreted into the colon and has no efficacy against CDI; only oral or rectal vancomycin works 2, 3.
Do not delay treatment while waiting for laboratory confirmation in fulminant cases—start empiric therapy immediately 1.
Do not use Augmentin thinking it will help—it will make the infection worse by further disrupting the gut microbiome and promoting C. difficile toxin production 2, 3.